These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4363446

  • 1. Carcinogenic effect of N-nitrosoamines related to butyl(4-hydroxybutyl)nitrosoamine in ACI-N rats, with special reference to induction of urinary bladder tumors.
    Okada M, Hashimoto Y.
    Gan; 1974 Feb; 65(1):13-9. PubMed ID: 4363446
    [No Abstract] [Full Text] [Related]

  • 2. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M, Suzuki E, Hashimoto Y.
    Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics of the carcinogenic action of dibutylnitrosamine].
    Vlasov NN, Dzhioev FK, Pliss GB.
    Vopr Onkol; 1973 Dec; 19(4):55-9. PubMed ID: 4352995
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H, Miyata Y, Murasaki G, Kinoshita H, Fukushima S.
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract] [Full Text] [Related]

  • 7. Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine.
    Hashimoto Y, Suzuki E, Okada M.
    Gan; 1972 Oct; 63(5):637-8. PubMed ID: 4645279
    [No Abstract] [Full Text] [Related]

  • 8. Effect of various carcinogenic and non-carcinogenic substances on development of bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosoamine.
    Ito N, Matayoshi K, Matsumura K, Denda A, Kani T.
    Gan; 1974 Apr; 65(2):123-30. PubMed ID: 4837987
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M, Miyata Y, Mizutani M, Hananouchi M, Hirose M.
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [Abstract] [Full Text] [Related]

  • 13. [Experimental studies os syncarcinogenesis in esophageal carcinoma].
    Gibel W.
    Arch Geschwulstforsch; 1967 Apr; 30(3):181-9. PubMed ID: 4299442
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
    Komatsu H, Kakizoe T, Nishio Y, Honma Y, Niijima T.
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.